Corrigendum to "In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis" [Int. J. Pharm. 535 (2018) 113-119].

Allan J Williams Faron Jordan Gareth King Andrew L Lewis Lisbeth Illum Tahir Masud Alan C Perkins Richard G Pearson

Int J Pharm

School of Medicine, Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK. Electronic address:

Published: August 2018

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ijpharm.2018.06.045	DOI Listing

Publication Analysis

Top Keywords

corrigendum "in

"in vitro

vitro preclinical

preclinical assessment

assessment intranasal

intranasal spray

spray formulation

formulation parathyroid

parathyroid hormone

hormone pth

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Corrigendum to "In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis" [Int. J. Pharm. 535 (2018) 113-119].

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?